Victoria Joan Dorr, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2412 50th St, Lubbock, TX 79412 Phone: 806-744-7223 Fax: 806-740-3325 |
Nicholas Cyril Dcunha, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 602 Indiana Ave, Lubbock, TX 79415 Phone: 806-775-8600 Fax: 806-775-8602 |
Everardo Cobos, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 |
Donald Paul Quick, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4101 22nd Place, Lubbock, TX 79410 Phone: 806-725-8000 |
Dr. Davor Vugrin, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2232 Indiana Ave, Suite 102, Lubbock, TX 79410 Phone: 806-793-0988 Fax: 806-793-1697 |
News Archive
Helicos BioSciences Corporation announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for patent infringement. The lawsuit, filed in the United States District Court for the District of Delaware, accuses PacBio of infringing four patents and seeks injunctive relief and monetary damages.
Along with copying and splitting DNA during division, cells must have a way to break safely into two viable daughter cells, a process called cytokinesis. But the molecular basis of how plant cells accomplish this without mistakes has been unclear for many years.
Overall, Swedish 70-year-olds' eyesight is good, but many could see even better. Six in ten can improve their vision by getting eyeglasses or changing the power of the glasses they already have, according to a new study from the University of Gothenburg.
Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus that causes AIDS.
Mutations in the adenomatous polyposis coli (APC) tumor suppressor gene have been found to cause 85 percent of colon cancers.
› Verified 9 days ago